Document is current
Any future updates will be listed below
-
Authors
Bazarbachi, Ali https://orcid.org/0000-0002-7171-4997
Labopin, Myriam https://orcid.org/0000-0003-4514-4748
Blaise, Didier https://orcid.org/0000-0002-5684-9447
Forcade, Edouard
Socié, Gerard https://orcid.org/0000-0002-2114-7533
Berceanu, Ana
Angelucci, Emanuele https://orcid.org/0000-0002-6512-6080
Bulabois, Claude Eric
Kröger, Nicolaus https://orcid.org/0000-0002-2961-4183
Rambaldi, Alessandro https://orcid.org/0000-0002-3739-7502
Ceballos, Patrice
Mielke, Stephan https://orcid.org/0000-0002-8325-9215
El Cheikh, Jean https://orcid.org/0000-0003-2846-9428
Yakoub-Agha, Ibrahim
Savani, Bipin
Spyridonidis, Alexandros https://orcid.org/0000-0003-3097-2532
Nagler, Arnon
Mohty, Mohamad
- License Information
-
More Information
Article History
Received: 10 April 2020
Revised: 15 September 2020
Accepted: 22 September 2020
First Online: 6 October 2020
Compliance with ethical standards
:
: AB received honorarium from Jazz, Adienne, and Sanofi. MM received honorarium from Jazz, Riemser, and Sanofi. EA reports personal fees from Novartis, Jazz Pharmaceuticals, Bluebird Bio, Roche, Celgene, Vertex Pharmaceuticals, and CRISPR Therapeutics all outside the submitted work. All remaining authors do not have any conflicts of interest.
